Evidence Level
Moderate Evidence
Mechanism of Action
Binds KISS1R (GPR54) on GnRH neurons, triggering GnRH pulsatility. Master regulator of HPG axis activation. Also studied for direct limbic effects on sexual behavior.
Published Research Ranges & Study Context
Studies have administered: 1–10nmol/kg bolus; 10nmol/min infusion in clinical studies
Important Research Framing
These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings
Human RCTs demonstrate LH/FSH stimulation in hypogonadal men and women. Sexual desire improvements in MRI-based limbic activation studies. NICE-published research.
Moderate Evidence
Phase 1/2 human trials available
Side Effects Observed in Research
Generally well-tolerated; occasional nausea, flushing in research subjects
Available Configurations (SKU Reference)
KS5
KS10
Compounds Studied in Combination
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Kisspeptin-10 — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.